Cell cycle related behavior of a chromosomal scaffold protein in MDCK epithelial cells

D E Vega-Salas1, P J Salas

  • 1Department of Cell Biology and Anatomy, University of Miami School of Medicine, P.O. Box 016960, Miami, FL 33101, USA.

Chromosoma
|January 1, 1996
PubMed

Insights

Researchers identified a novel Mr58000 protein in MDCK cells that associates with chromosomes during M-phase. This protein acts as a chromosomal scaffold and shows cell cycle-dependent localization, suggesting a role in cell growth regulation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Understanding cell growth requires knowledge of mitosis mechanisms.
  • Proteins associated with chromosomes during M-phase are crucial for cell cycle regulation.

Purpose of the Study:

  • To identify and characterize novel proteins associated with chromosomes during M-phase.
  • To investigate the role of a specific Mr58000 protein, recognized by antibody LFM-1, in mitosis and cell cycle progression.

Main Methods:

  • Monoclonal antibody production (LFM-1) and characterization.
  • Cell fractionation, immunoblotting, and immunofluorescence microscopy.
  • Biochemical extraction of isolated metaphase chromosomes.
  • Confocal microscopy and flow cytometry for cell cycle analysis.
  • Edman degradation for protein sequencing.

Main Results:

  • A Mr58000 protein was identified in MDCK cells, decorating chromosomes during M-phase.
  • This protein behaves as a chromosomal scaffold, remaining associated with chromosomes after high salt and DNase treatments.
  • LFM-1 epitopes show distinct localization on mitotic chromosomes and are present in G1 but excluded from G2 interphase nuclei.
  • The Mr58000 protein shares N-terminal sequence homology with a minor Mr38000 protein but shows no homology to known proteins.

Conclusions:

  • The identified Mr58000 protein is a chromosomal scaffold protein with cell cycle-dependent localization.
  • These findings support the licensing factor model and suggest a role in cell cycle-dependent events.
  • The LFM-1 antigens represent novel proteins potentially involved in regulating mitosis and cell growth.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...